RecruitingNot ApplicableNCT06887556

Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks

Sponsor

University of Birmingham

Enrollment

650 participants

Start Date

Feb 5, 2025

Study Type

INTERVENTIONAL

Conditions

Mpox

Summary

The MPXV CARE study principally aims to use clinical and epidemiology data to target specific individuals willing and able to provide appropriate and proportionate biological samples to develop novel immune diagnostics that support models of disease burden and future vaccine utilisation.

Eligibility

Min Age: 5 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying ELISA and Lateral flow assay for people with mpox. The study is currently recruiting participants at 1 location. People eligible for this study include aged 5 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.